MedTrace Logo

Improvement on GMFCS Level of Patients With Cerebral Palsy Treated by Repeated Botulinum Toxin-A

NCT03344952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 503

Last updated 2018-11-30

No results posted yet for this study

Summary

The aim of this retrospective, monocenter, observational study is to evaluate the changes in GMFCS levels of children with cerebral palsy (CP) who received repeated Botulinum Toxin-A (BoNT-A) injections in the lower limb(s) with an integrated treatment approach in Kocaeli University Department of PMR and Izmit Rehabilitation Center.

Conditions

  • Cerebral Palsy

Interventions

DRUG

Botulinum toxin type A

Repeated injections to hypertonic muscles

OTHER

Physical therapy

3 weeks intensive program 1 week -10 days after BoNT-A injections

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-20
Primary Completion
2018-10-10
Completion
2018-11-09

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03344952 on ClinicalTrials.gov